• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Study finds no harm from hospital policies that let families observe CPR

, 26 August 2020/in E-News /by 3wmedia

When a hospital patient

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:43Study finds no harm from hospital policies that let families observe CPR

HIV prevention study demonstrates sustained benefit of early antiretroviral therapy

, 26 August 2020/in E-News /by 3wmedia

Antiretroviral therapy (ART) for HIV infection provides lasting protection against the sexual transmission of the virus from infected men and women to their HIV-uninfected sexual partners, investigators from the HIV Prevention Trials Network (HPTN) reported today at the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada. The study, known as HPTN 052, began in 2005 and enrolled 1,763 HIV sero-discordant couples

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:23HIV prevention study demonstrates sustained benefit of early antiretroviral therapy

Removing more tissue during breast cancer surgery reduces by half the need for second procedure

, 26 August 2020/in E-News /by 3wmedia

Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study.

Nearly 300,000 women in the United States are diagnosed with breast cancer each year; more than half undergo breast-conserving surgery with a partial mastectomy to remove the disease. However, between 20% and 40% of patients who undergo this procedure have

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:31Removing more tissue during breast cancer surgery reduces by half the need for second procedure

Growing a blood vessel in a week

, 26 August 2020/in E-News /by 3wmedia

The technology for creating new tissues from stem cells has taken a giant leap forward. Two tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown in a new study from Sahlgrenska Acadedmy and Sahlgrenska University Hospital.
Just three years ago, a patient at Sahlgrenska University Hospital received a blood vessel transplant grown from her own stem cells.
Suchitra Sumitran-Holgersson, Professor of Transplantation Biology at Sahlgrenska Academy, and Michael Olausson, Surgeon/Medical Director of the Transplant Center and Professor at Sahlgrenska Academy, came up with the idea, planned and carried out the procedure. Professors Sumitran-Holgersson and Olausson have published a new study based on two other transplants that were performed in 2012 at Sahlgrenska University Hospital. The patients, two young children, had the same condition as in the first case

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:38Growing a blood vessel in a week

A lightweight, portable system to produce the gas nitric oxide from the air

, 26 August 2020/in E-News /by 3wmedia

Treatment with inhaled nitric oxide (NO) has proven to be life saving in newborns, children and adults with several dangerous conditions, but the availability of the treatment has been limited by the size, weight and complexity of equipment needed to administer the gas and the therapy

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:26A lightweight, portable system to produce the gas nitric oxide from the air

Livers donated after cardiac death safe to use in liver cancer patients

, 26 August 2020/in E-News /by 3wmedia

Patients with liver cancer can be cured with a liver transplant. But because of the shortage of donated organs, these patients often die waiting for a liver. That

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:33Livers donated after cardiac death safe to use in liver cancer patients

Combined chemotherapy and immunotherapy shows promise for advanced prostate cancers

, 26 August 2020/in E-News /by 3wmedia

Immune cell manipulation plus chemotherapy achieves prostate cancer remission in mouse models where chemotherapy alone fails

Chemotherapy can be very effective against small prostate tumours. Larger prostate tumours, however, accumulate cells that suppress the body

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:41Combined chemotherapy and immunotherapy shows promise for advanced prostate cancers

Scientists identify a potential new treatment for osteoporosis

, 26 August 2020/in E-News /by 3wmedia

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a new therapeutic approach that, while still preliminary, could promote the development of new bone-forming cells in patients suffering from bone loss.

The study focused on a protein called PPARy (known as the master regulator of fat) and its impact on the fate of stem cells derived from bone marrow (

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:28Scientists identify a potential new treatment for osteoporosis

Early physical rehabilitation in the ICU leads to better patient outcomes

, 26 August 2020/in E-News /by 3wmedia

In a pre- and post-evaluation study, Johns Hopkins Medicine researchers found that quality improvement processes for delivering early physical rehabilitation in an intensive care unit (ICU) were sustained five years later

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:36Early physical rehabilitation in the ICU leads to better patient outcomes

Optical resonance-based biosensors designed for medical applications

, 26 August 2020/in E-News /by 3wmedia

A telecommunications engineer of the NUP/UPNA-Public University of Navarre, has designed optical resonance-based biosensors for use in medical applications like, for example, the detecting of celiac disease. Besides achieving greater resolution and sensitivity, the materials used in these devices are much cheaper and more versatile than the ones used in current technologies (mainly gold and noble metals) so they could offer a potential alternative in the design of biomedical sensors.

A biosensor is an instrument that uses biological molecules (bioreceptors) to detect other biological or chemical substances. In this thesis the bioreceptors have been antibodies, biological molecules that the body produces specifically to fight off antigens. An antigen is a substance foreign to the human body; our immune system recognises it as a threat and in the presence of it the body reacts by producing antibodies to identify and neutralise it. What is more, the biosensor is made up of a substrate (where the physical phenomenon that translates the biological reactions into intelligible information takes place) and the immobilisation layer which causes the antibodies to become attached to the substrate.

‘One of the unique features,’ says the author, ‘is that for the substrate we use silicon waveguides on which we generate a specific type of resonance.’ The biosensors designed are based on the movement of the wavelength of the resonances generated on the basis of the quantity of antigens detected. ‘When the antibodies come together with the antigens, there is a minimum change in the wavelength that our biosensors are capable of picking up.’ This is possible thanks to the resolution achieved by these biosensors and their sensitivity, ‘which enables us to see how much resonances shift on the wavelength as the antibody-antigen links increase.’

The work carried out by Abi

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:43Optical resonance-based biosensors designed for medical applications
Page 141 of 237«‹139140141142143›»

Latest issue of International Hospital

April 2024

5 November 2025

New NextBrain atlas enables unprecedented granularity in human brain imaging analysis

5 November 2025

ERIS project launches to standardise European simulation training

4 November 2025

Ageing populations are driving drug-resistant infection surge across Europe

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Tramstraat 15
5611CM Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription